Machine learning identifies risk of type 2 diabetes in low-resource settings, highlighting potential for early detection.
Type 2 Diabetes Mellitus (T2DM) is a growing public health concern in low-resource settings, where early detection remains limited due to infrastructural and diagnostic constraints. This study presents a machine learning-based risk prediction model developed using real-world data from Kilifi County Referral Hospital in Kenya, aiming to identify individuals at risk of developing T2DM before clinical onset. The study applied the CRISP-DM framework to guide the end-to-end process, from data collection to model deployment. A dataset comprising 2,500 anonymized electronic health records was used, incorporating a diverse range of features including clinical, behavioral, demographic, and socioeconomic variables. Feature selection was conducted using both statistical (Chi-square test) and algorithm-based methods (Random Forest, Recursive Feature Elimination, and XGBoost importance), resulting in two candidate feature sets (14-feature and 7-feature subsets). Four supervised learning algorithms; Logistic Regression, Support Vector Machine (SVM), Random Forest, and XGBoost were trained and evaluated using 5-fold cross-validation. Among them, the XGBoost model achieved the best performance, with a test set accuracy of 91.33%, F1-score of 88.66%, and an AUC-ROC of 96.24%, outperforming other models across all metrics. This study demonstrates that integrating multi-domain features with machine learning can enhance early risk stratification for T2DM in under-resourced environments. The final model’s ability to categorize individuals into low, medium, and high-risk groups offers a practical tool for targeted screening and preventive healthcare interventions in Kenyan public health systems.
No takes yet. Share an insight, caveat, or question.
Kailu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: